Hereditary Angioedema Treatment Market Outlook: Size, Share, Trends, Growth Analysis, Competitive Landscape & Forecast, 2026-2033

The Hereditary Angioedema Treatment Market size was valued at US$ 6.85 billion in 2025 and is projected to reach US$ 26.07 billion by 2033, growing at a CAGR of 18.18% during 2026–2033. Increasing disease awareness, expanding access to targeted biologics, and rising adoption of preventive therapies continue accelerating treatment demand across developed and emerging healthcare systems.

Report Coverage

Drug Class: C-1 Esterase Inhibitors, Bradykinin Receptor Antagonist, Kallikrein Inhibitors
Application: Prophylaxis, Treatment
Route of Administration: IV, Subcutaneous
Distribution Channel: Hospital Pharmacy, Retail Pharmacy

US$ 6.85 Bn Market size in 2025

US$ 26.07 Bn Market Size by 2033

18.18% CAGR, 2026 - 2033

2026-2033 Forecast Period

Download Sample PDF Buy Now

Format PDF + Excel + PPT

No. of Pages: 350

Category Life Sciences

Report Code: BMIPUB00038084

Last Updated: 2026-08-19

Author

Krishna Sunthwal

Analyst Connect

1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Data Triangulation and Validation

4. Hereditary Angioedema Treatment Market Landscape

4.1 Overview

4.3 Ecosystem Analysis

4.3.1 List of Vendors in the Value Chain

5. Hereditary Angioedema Treatment Market – Key Market Dynamics

5.1 Market Drivers

5.2 Market Restraints

5.3 Market Opportunities

5.4 Future Trends

5.5 Impact of Drivers and Restraints

6. Hereditary Angioedema Treatment Market Global Analysis

6.2 Hereditary Angioedema Treatment Market Revenue 2022-2033 (US$ Billion)

6.3 Hereditary Angioedema Treatment Market Forecast Analysis

7. Hereditary Angioedema Treatment Market Analysis – by Drug Class

7.1 C-1 Esterase Inhibitors

7.1.1 Overview
7.1.2 C-1 Esterase Inhibitors: Hereditary Angioedema Treatment Market – Revenue and Forecast, 2022-2033 (US$ Billion)

7.2 Bradykinin Receptor Antagonist

7.2.1 Overview
7.2.2 Bradykinin Receptor Antagonist: Hereditary Angioedema Treatment Market – Revenue and Forecast, 2022-2033 (US$ Billion)

7.3 Kallikrein Inhibitors

7.3.1 Overview
7.3.2 Kallikrein Inhibitors: Hereditary Angioedema Treatment Market – Revenue and Forecast, 2022-2033 (US$ Billion)

8. Hereditary Angioedema Treatment Market Analysis – by Application

8.1 Prophylaxis

8.1.1 Overview
8.1.2 Prophylaxis: Hereditary Angioedema Treatment Market – Revenue and Forecast, 2022-2033 (US$ Billion)

8.2 Treatment

8.2.1 Overview
8.2.2 Treatment: Hereditary Angioedema Treatment Market – Revenue and Forecast, 2022-2033 (US$ Billion)

9. Hereditary Angioedema Treatment Market Analysis – by Route of Administration

9.1 IV

9.1.1 Overview
9.1.2 IV: Hereditary Angioedema Treatment Market – Revenue and Forecast, 2022-2033 (US$ Billion)

9.2 Subcutaneous

9.2.1 Overview
9.2.2 Subcutaneous: Hereditary Angioedema Treatment Market – Revenue and Forecast, 2022-2033 (US$ Billion)

10. Hereditary Angioedema Treatment Market Analysis – by Distribution Channel

10.1 Hospital Pharmacy

10.1.1 Overview
10.1.2 Hospital Pharmacy: Hereditary Angioedema Treatment Market – Revenue and Forecast, 2022-2033 (US$ Billion)

10.2 Retail Pharmacy

10.2.1 Overview
10.2.2 Retail Pharmacy: Hereditary Angioedema Treatment Market – Revenue and Forecast, 2022-2033 (US$ Billion)

11. Hereditary Angioedema Treatment Market – Geographic Analysis

11.1 Overview

11.2 North America

11.2.1 Hereditary Angioedema Treatment Market Breakdown, by Key Country, 2026 and 2033 (%)
11.2.1.1 Hereditary Angioedema Treatment Market – Revenue and Forecast Analysis – by Country
11.2.1.1 US: Hereditary Angioedema Treatment Market – Revenue and Forecast to 2033 (US$ Billion)

11.2.1.1.1 US: Hereditary Angioedema Treatment Market Breakdown, by Drug Class
11.2.1.1.2 US: Hereditary Angioedema Treatment Market Breakdown, by Application
11.2.1.1.3 US: Hereditary Angioedema Treatment Market Breakdown, by Route of Administration
11.2.1.1.4 US: Hereditary Angioedema Treatment Market Breakdown, by Distribution Channel

11.2.1.2 Canada: Hereditary Angioedema Treatment Market – Revenue and Forecast to 2033 (US$ Billion)

11.2.1.2.1 Canada: Hereditary Angioedema Treatment Market Breakdown, by Drug Class
11.2.1.2.2 Canada: Hereditary Angioedema Treatment Market Breakdown, by Application
11.2.1.2.3 Canada: Hereditary Angioedema Treatment Market Breakdown, by Route of Administration
11.2.1.2.4 Canada: Hereditary Angioedema Treatment Market Breakdown, by Distribution Channel

11.2.1.3 Mexico : Hereditary Angioedema Treatment Market – Revenue and Forecast to 2033 (US$ Billion)

11.2.1.3.1 Mexico : Hereditary Angioedema Treatment Market Breakdown, by Drug Class
11.2.1.3.2 Mexico : Hereditary Angioedema Treatment Market Breakdown, by Application
11.2.1.3.3 Mexico : Hereditary Angioedema Treatment Market Breakdown, by Route of Administration
11.2.1.3.4 Mexico : Hereditary Angioedema Treatment Market Breakdown, by Distribution Channel

11.3 Europe

11.3.1 Hereditary Angioedema Treatment Market Breakdown, by Key Country, 2026 and 2033 (%)
11.3.1.1 Hereditary Angioedema Treatment Market – Revenue and Forecast Analysis – by Country
11.3.1.1 Germany: Hereditary Angioedema Treatment Market – Revenue and Forecast to 2033 (US$ Billion)

11.3.1.1.1 Germany: Hereditary Angioedema Treatment Market Breakdown, by Drug Class
11.3.1.1.2 Germany: Hereditary Angioedema Treatment Market Breakdown, by Application
11.3.1.1.3 Germany: Hereditary Angioedema Treatment Market Breakdown, by Route of Administration
11.3.1.1.4 Germany: Hereditary Angioedema Treatment Market Breakdown, by Distribution Channel

11.3.1.2 Italy: Hereditary Angioedema Treatment Market – Revenue and Forecast to 2033 (US$ Billion)

11.3.1.2.1 Italy: Hereditary Angioedema Treatment Market Breakdown, by Drug Class
11.3.1.2.2 Italy: Hereditary Angioedema Treatment Market Breakdown, by Application
11.3.1.2.3 Italy: Hereditary Angioedema Treatment Market Breakdown, by Route of Administration
11.3.1.2.4 Italy: Hereditary Angioedema Treatment Market Breakdown, by Distribution Channel

11.3.1.3 France: Hereditary Angioedema Treatment Market – Revenue and Forecast to 2033 (US$ Billion)

11.3.1.3.1 France: Hereditary Angioedema Treatment Market Breakdown, by Drug Class
11.3.1.3.2 France: Hereditary Angioedema Treatment Market Breakdown, by Application
11.3.1.3.3 France: Hereditary Angioedema Treatment Market Breakdown, by Route of Administration
11.3.1.3.4 France: Hereditary Angioedema Treatment Market Breakdown, by Distribution Channel

11.3.1.4 U.K.: Hereditary Angioedema Treatment Market – Revenue and Forecast to 2033 (US$ Billion)

11.3.1.4.1 U.K.: Hereditary Angioedema Treatment Market Breakdown, by Drug Class
11.3.1.4.2 U.K.: Hereditary Angioedema Treatment Market Breakdown, by Application
11.3.1.4.3 U.K.: Hereditary Angioedema Treatment Market Breakdown, by Route of Administration
11.3.1.4.4 U.K.: Hereditary Angioedema Treatment Market Breakdown, by Distribution Channel

11.3.1.5 Spain: Hereditary Angioedema Treatment Market – Revenue and Forecast to 2033 (US$ Billion)

11.3.1.5.1 Spain: Hereditary Angioedema Treatment Market Breakdown, by Drug Class
11.3.1.5.2 Spain: Hereditary Angioedema Treatment Market Breakdown, by Application
11.3.1.5.3 Spain: Hereditary Angioedema Treatment Market Breakdown, by Route of Administration
11.3.1.5.4 Spain: Hereditary Angioedema Treatment Market Breakdown, by Distribution Channel

11.3.1.6 Belgium: Hereditary Angioedema Treatment Market – Revenue and Forecast to 2033 (US$ Billion)

11.3.1.6.1 Belgium: Hereditary Angioedema Treatment Market Breakdown, by Drug Class
11.3.1.6.2 Belgium: Hereditary Angioedema Treatment Market Breakdown, by Application
11.3.1.6.3 Belgium: Hereditary Angioedema Treatment Market Breakdown, by Route of Administration
11.3.1.6.4 Belgium: Hereditary Angioedema Treatment Market Breakdown, by Distribution Channel

11.3.1.7 Netherlands: Hereditary Angioedema Treatment Market – Revenue and Forecast to 2033 (US$ Billion)

11.3.1.7.1 Netherlands: Hereditary Angioedema Treatment Market Breakdown, by Drug Class
11.3.1.7.2 Netherlands: Hereditary Angioedema Treatment Market Breakdown, by Application
11.3.1.7.3 Netherlands: Hereditary Angioedema Treatment Market Breakdown, by Route of Administration
11.3.1.7.4 Netherlands: Hereditary Angioedema Treatment Market Breakdown, by Distribution Channel

11.3.1.8 Luxembourg: Hereditary Angioedema Treatment Market – Revenue and Forecast to 2033 (US$ Billion)

11.3.1.8.1 Luxembourg: Hereditary Angioedema Treatment Market Breakdown, by Drug Class
11.3.1.8.2 Luxembourg: Hereditary Angioedema Treatment Market Breakdown, by Application
11.3.1.8.3 Luxembourg: Hereditary Angioedema Treatment Market Breakdown, by Route of Administration
11.3.1.8.4 Luxembourg: Hereditary Angioedema Treatment Market Breakdown, by Distribution Channel

11.3.1.9 Norway: Hereditary Angioedema Treatment Market – Revenue and Forecast to 2033 (US$ Billion)

11.3.1.9.1 Norway: Hereditary Angioedema Treatment Market Breakdown, by Drug Class
11.3.1.9.2 Norway: Hereditary Angioedema Treatment Market Breakdown, by Application
11.3.1.9.3 Norway: Hereditary Angioedema Treatment Market Breakdown, by Route of Administration
11.3.1.9.4 Norway: Hereditary Angioedema Treatment Market Breakdown, by Distribution Channel

11.3.1.10 Finland: Hereditary Angioedema Treatment Market – Revenue and Forecast to 2033 (US$ Billion)

11.3.1.10.1 Finland: Hereditary Angioedema Treatment Market Breakdown, by Drug Class
11.3.1.10.2 Finland: Hereditary Angioedema Treatment Market Breakdown, by Application
11.3.1.10.3 Finland: Hereditary Angioedema Treatment Market Breakdown, by Route of Administration
11.3.1.10.4 Finland: Hereditary Angioedema Treatment Market Breakdown, by Distribution Channel

11.3.1.11 Denmark: Hereditary Angioedema Treatment Market – Revenue and Forecast to 2033 (US$ Billion)

11.3.1.11.1 Denmark: Hereditary Angioedema Treatment Market Breakdown, by Drug Class
11.3.1.11.2 Denmark: Hereditary Angioedema Treatment Market Breakdown, by Application
11.3.1.11.3 Denmark: Hereditary Angioedema Treatment Market Breakdown, by Route of Administration
11.3.1.11.4 Denmark: Hereditary Angioedema Treatment Market Breakdown, by Distribution Channel

11.3.1.12 Sweden: Hereditary Angioedema Treatment Market – Revenue and Forecast to 2033 (US$ Billion)

11.3.1.12.1 Sweden: Hereditary Angioedema Treatment Market Breakdown, by Drug Class
11.3.1.12.2 Sweden: Hereditary Angioedema Treatment Market Breakdown, by Application
11.3.1.12.3 Sweden: Hereditary Angioedema Treatment Market Breakdown, by Route of Administration
11.3.1.12.4 Sweden: Hereditary Angioedema Treatment Market Breakdown, by Distribution Channel

11.3.1.13 Switzerland: Hereditary Angioedema Treatment Market – Revenue and Forecast to 2033 (US$ Billion)

11.3.1.13.1 Switzerland: Hereditary Angioedema Treatment Market Breakdown, by Drug Class
11.3.1.13.2 Switzerland: Hereditary Angioedema Treatment Market Breakdown, by Application
11.3.1.13.3 Switzerland: Hereditary Angioedema Treatment Market Breakdown, by Route of Administration
11.3.1.13.4 Switzerland: Hereditary Angioedema Treatment Market Breakdown, by Distribution Channel

11.3.1.14 Austria: Hereditary Angioedema Treatment Market – Revenue and Forecast to 2033 (US$ Billion)

11.3.1.14.1 Austria: Hereditary Angioedema Treatment Market Breakdown, by Drug Class
11.3.1.14.2 Austria: Hereditary Angioedema Treatment Market Breakdown, by Application
11.3.1.14.3 Austria: Hereditary Angioedema Treatment Market Breakdown, by Route of Administration
11.3.1.14.4 Austria: Hereditary Angioedema Treatment Market Breakdown, by Distribution Channel

11.3.1.15 Greece: Hereditary Angioedema Treatment Market – Revenue and Forecast to 2033 (US$ Billion)

11.3.1.15.1 Greece: Hereditary Angioedema Treatment Market Breakdown, by Drug Class
11.3.1.15.2 Greece: Hereditary Angioedema Treatment Market Breakdown, by Application
11.3.1.15.3 Greece: Hereditary Angioedema Treatment Market Breakdown, by Route of Administration
11.3.1.15.4 Greece: Hereditary Angioedema Treatment Market Breakdown, by Distribution Channel

11.3.1.16 Portugal: Hereditary Angioedema Treatment Market – Revenue and Forecast to 2033 (US$ Billion)

11.3.1.16.1 Portugal: Hereditary Angioedema Treatment Market Breakdown, by Drug Class
11.3.1.16.2 Portugal: Hereditary Angioedema Treatment Market Breakdown, by Application
11.3.1.16.3 Portugal: Hereditary Angioedema Treatment Market Breakdown, by Route of Administration
11.3.1.16.4 Portugal: Hereditary Angioedema Treatment Market Breakdown, by Distribution Channel

11.3.1.17 Russia: Hereditary Angioedema Treatment Market – Revenue and Forecast to 2033 (US$ Billion)

11.3.1.17.1 Russia: Hereditary Angioedema Treatment Market Breakdown, by Drug Class
11.3.1.17.2 Russia: Hereditary Angioedema Treatment Market Breakdown, by Application
11.3.1.17.3 Russia: Hereditary Angioedema Treatment Market Breakdown, by Route of Administration
11.3.1.17.4 Russia: Hereditary Angioedema Treatment Market Breakdown, by Distribution Channel

11.3.1.18 Poland: Hereditary Angioedema Treatment Market – Revenue and Forecast to 2033 (US$ Billion)

11.3.1.18.1 Poland: Hereditary Angioedema Treatment Market Breakdown, by Drug Class
11.3.1.18.2 Poland: Hereditary Angioedema Treatment Market Breakdown, by Application
11.3.1.18.3 Poland: Hereditary Angioedema Treatment Market Breakdown, by Route of Administration
11.3.1.18.4 Poland: Hereditary Angioedema Treatment Market Breakdown, by Distribution Channel

11.3.1.19 Romania: Hereditary Angioedema Treatment Market – Revenue and Forecast to 2033 (US$ Billion)

11.3.1.19.1 Romania: Hereditary Angioedema Treatment Market Breakdown, by Drug Class
11.3.1.19.2 Romania: Hereditary Angioedema Treatment Market Breakdown, by Application
11.3.1.19.3 Romania: Hereditary Angioedema Treatment Market Breakdown, by Route of Administration
11.3.1.19.4 Romania: Hereditary Angioedema Treatment Market Breakdown, by Distribution Channel

11.3.1.20 Czech Republic: Hereditary Angioedema Treatment Market – Revenue and Forecast to 2033 (US$ Billion)

11.3.1.20.1 Czech Republic: Hereditary Angioedema Treatment Market Breakdown, by Drug Class
11.3.1.20.2 Czech Republic: Hereditary Angioedema Treatment Market Breakdown, by Application
11.3.1.20.3 Czech Republic: Hereditary Angioedema Treatment Market Breakdown, by Route of Administration
11.3.1.20.4 Czech Republic: Hereditary Angioedema Treatment Market Breakdown, by Distribution Channel

11.3.1.21 Ukraine: Hereditary Angioedema Treatment Market – Revenue and Forecast to 2033 (US$ Billion)

11.3.1.21.1 Ukraine: Hereditary Angioedema Treatment Market Breakdown, by Drug Class
11.3.1.21.2 Ukraine: Hereditary Angioedema Treatment Market Breakdown, by Application
11.3.1.21.3 Ukraine: Hereditary Angioedema Treatment Market Breakdown, by Route of Administration
11.3.1.21.4 Ukraine: Hereditary Angioedema Treatment Market Breakdown, by Distribution Channel

11.3.1.22 Slovakia: Hereditary Angioedema Treatment Market – Revenue and Forecast to 2033 (US$ Billion)

11.3.1.22.1 Slovakia: Hereditary Angioedema Treatment Market Breakdown, by Drug Class
11.3.1.22.2 Slovakia: Hereditary Angioedema Treatment Market Breakdown, by Application
11.3.1.22.3 Slovakia: Hereditary Angioedema Treatment Market Breakdown, by Route of Administration
11.3.1.22.4 Slovakia: Hereditary Angioedema Treatment Market Breakdown, by Distribution Channel

11.3.1.23 Bulgaria : Hereditary Angioedema Treatment Market – Revenue and Forecast to 2033 (US$ Billion)

11.3.1.23.1 Bulgaria : Hereditary Angioedema Treatment Market Breakdown, by Drug Class
11.3.1.23.2 Bulgaria : Hereditary Angioedema Treatment Market Breakdown, by Application
11.3.1.23.3 Bulgaria : Hereditary Angioedema Treatment Market Breakdown, by Route of Administration
11.3.1.23.4 Bulgaria : Hereditary Angioedema Treatment Market Breakdown, by Distribution Channel

11.4 Asia-Pacific

11.4.1 Hereditary Angioedema Treatment Market Breakdown, by Key Country, 2026 and 2033 (%)
11.4.1.1 Hereditary Angioedema Treatment Market – Revenue and Forecast Analysis – by Country
11.4.1.1 China: Hereditary Angioedema Treatment Market – Revenue and Forecast to 2033 (US$ Billion)

11.4.1.1.1 China: Hereditary Angioedema Treatment Market Breakdown, by Drug Class
11.4.1.1.2 China: Hereditary Angioedema Treatment Market Breakdown, by Application
11.4.1.1.3 China: Hereditary Angioedema Treatment Market Breakdown, by Route of Administration
11.4.1.1.4 China: Hereditary Angioedema Treatment Market Breakdown, by Distribution Channel

11.4.1.2 Japan: Hereditary Angioedema Treatment Market – Revenue and Forecast to 2033 (US$ Billion)

11.4.1.2.1 Japan: Hereditary Angioedema Treatment Market Breakdown, by Drug Class
11.4.1.2.2 Japan: Hereditary Angioedema Treatment Market Breakdown, by Application
11.4.1.2.3 Japan: Hereditary Angioedema Treatment Market Breakdown, by Route of Administration
11.4.1.2.4 Japan: Hereditary Angioedema Treatment Market Breakdown, by Distribution Channel

11.4.1.3 South Korea: Hereditary Angioedema Treatment Market – Revenue and Forecast to 2033 (US$ Billion)

11.4.1.3.1 South Korea: Hereditary Angioedema Treatment Market Breakdown, by Drug Class
11.4.1.3.2 South Korea: Hereditary Angioedema Treatment Market Breakdown, by Application
11.4.1.3.3 South Korea: Hereditary Angioedema Treatment Market Breakdown, by Route of Administration
11.4.1.3.4 South Korea: Hereditary Angioedema Treatment Market Breakdown, by Distribution Channel

11.4.1.4 India: Hereditary Angioedema Treatment Market – Revenue and Forecast to 2033 (US$ Billion)

11.4.1.4.1 India: Hereditary Angioedema Treatment Market Breakdown, by Drug Class
11.4.1.4.2 India: Hereditary Angioedema Treatment Market Breakdown, by Application
11.4.1.4.3 India: Hereditary Angioedema Treatment Market Breakdown, by Route of Administration
11.4.1.4.4 India: Hereditary Angioedema Treatment Market Breakdown, by Distribution Channel

11.4.1.5 Australia: Hereditary Angioedema Treatment Market – Revenue and Forecast to 2033 (US$ Billion)

11.4.1.5.1 Australia: Hereditary Angioedema Treatment Market Breakdown, by Drug Class
11.4.1.5.2 Australia: Hereditary Angioedema Treatment Market Breakdown, by Application
11.4.1.5.3 Australia: Hereditary Angioedema Treatment Market Breakdown, by Route of Administration
11.4.1.5.4 Australia: Hereditary Angioedema Treatment Market Breakdown, by Distribution Channel

11.4.1.6 New Zealand: Hereditary Angioedema Treatment Market – Revenue and Forecast to 2033 (US$ Billion)

11.4.1.6.1 New Zealand: Hereditary Angioedema Treatment Market Breakdown, by Drug Class
11.4.1.6.2 New Zealand: Hereditary Angioedema Treatment Market Breakdown, by Application
11.4.1.6.3 New Zealand: Hereditary Angioedema Treatment Market Breakdown, by Route of Administration
11.4.1.6.4 New Zealand: Hereditary Angioedema Treatment Market Breakdown, by Distribution Channel

11.4.1.7 Indonesia: Hereditary Angioedema Treatment Market – Revenue and Forecast to 2033 (US$ Billion)

11.4.1.7.1 Indonesia: Hereditary Angioedema Treatment Market Breakdown, by Drug Class
11.4.1.7.2 Indonesia: Hereditary Angioedema Treatment Market Breakdown, by Application
11.4.1.7.3 Indonesia: Hereditary Angioedema Treatment Market Breakdown, by Route of Administration
11.4.1.7.4 Indonesia: Hereditary Angioedema Treatment Market Breakdown, by Distribution Channel

11.4.1.8 Malaysia: Hereditary Angioedema Treatment Market – Revenue and Forecast to 2033 (US$ Billion)

11.4.1.8.1 Malaysia: Hereditary Angioedema Treatment Market Breakdown, by Drug Class
11.4.1.8.2 Malaysia: Hereditary Angioedema Treatment Market Breakdown, by Application
11.4.1.8.3 Malaysia: Hereditary Angioedema Treatment Market Breakdown, by Route of Administration
11.4.1.8.4 Malaysia: Hereditary Angioedema Treatment Market Breakdown, by Distribution Channel

11.4.1.9 Philippines: Hereditary Angioedema Treatment Market – Revenue and Forecast to 2033 (US$ Billion)

11.4.1.9.1 Philippines: Hereditary Angioedema Treatment Market Breakdown, by Drug Class
11.4.1.9.2 Philippines: Hereditary Angioedema Treatment Market Breakdown, by Application
11.4.1.9.3 Philippines: Hereditary Angioedema Treatment Market Breakdown, by Route of Administration
11.4.1.9.4 Philippines: Hereditary Angioedema Treatment Market Breakdown, by Distribution Channel

11.4.1.10 Singapore: Hereditary Angioedema Treatment Market – Revenue and Forecast to 2033 (US$ Billion)

11.4.1.10.1 Singapore: Hereditary Angioedema Treatment Market Breakdown, by Drug Class
11.4.1.10.2 Singapore: Hereditary Angioedema Treatment Market Breakdown, by Application
11.4.1.10.3 Singapore: Hereditary Angioedema Treatment Market Breakdown, by Route of Administration
11.4.1.10.4 Singapore: Hereditary Angioedema Treatment Market Breakdown, by Distribution Channel

11.4.1.11 Thailand: Hereditary Angioedema Treatment Market – Revenue and Forecast to 2033 (US$ Billion)

11.4.1.11.1 Thailand: Hereditary Angioedema Treatment Market Breakdown, by Drug Class
11.4.1.11.2 Thailand: Hereditary Angioedema Treatment Market Breakdown, by Application
11.4.1.11.3 Thailand: Hereditary Angioedema Treatment Market Breakdown, by Route of Administration
11.4.1.11.4 Thailand: Hereditary Angioedema Treatment Market Breakdown, by Distribution Channel

11.4.1.12 Vietnam: Hereditary Angioedema Treatment Market – Revenue and Forecast to 2033 (US$ Billion)

11.4.1.12.1 Vietnam: Hereditary Angioedema Treatment Market Breakdown, by Drug Class
11.4.1.12.2 Vietnam: Hereditary Angioedema Treatment Market Breakdown, by Application
11.4.1.12.3 Vietnam: Hereditary Angioedema Treatment Market Breakdown, by Route of Administration
11.4.1.12.4 Vietnam: Hereditary Angioedema Treatment Market Breakdown, by Distribution Channel

11.4.1.13 Taiwan: Hereditary Angioedema Treatment Market – Revenue and Forecast to 2033 (US$ Billion)

11.4.1.13.1 Taiwan: Hereditary Angioedema Treatment Market Breakdown, by Drug Class
11.4.1.13.2 Taiwan: Hereditary Angioedema Treatment Market Breakdown, by Application
11.4.1.13.3 Taiwan: Hereditary Angioedema Treatment Market Breakdown, by Route of Administration
11.4.1.13.4 Taiwan: Hereditary Angioedema Treatment Market Breakdown, by Distribution Channel

11.4.1.14 Bangladesh : Hereditary Angioedema Treatment Market – Revenue and Forecast to 2033 (US$ Billion)

11.4.1.14.1 Bangladesh : Hereditary Angioedema Treatment Market Breakdown, by Drug Class
11.4.1.14.2 Bangladesh : Hereditary Angioedema Treatment Market Breakdown, by Application
11.4.1.14.3 Bangladesh : Hereditary Angioedema Treatment Market Breakdown, by Route of Administration
11.4.1.14.4 Bangladesh : Hereditary Angioedema Treatment Market Breakdown, by Distribution Channel

11.5 South and Central America

11.5.1 Hereditary Angioedema Treatment Market Breakdown, by Key Country, 2026 and 2033 (%)
11.5.1.1 Hereditary Angioedema Treatment Market – Revenue and Forecast Analysis – by Country
11.5.1.1 Brazil: Hereditary Angioedema Treatment Market – Revenue and Forecast to 2033 (US$ Billion)

11.5.1.1.1 Brazil: Hereditary Angioedema Treatment Market Breakdown, by Drug Class
11.5.1.1.2 Brazil: Hereditary Angioedema Treatment Market Breakdown, by Application
11.5.1.1.3 Brazil: Hereditary Angioedema Treatment Market Breakdown, by Route of Administration
11.5.1.1.4 Brazil: Hereditary Angioedema Treatment Market Breakdown, by Distribution Channel

11.5.1.2 Argentina: Hereditary Angioedema Treatment Market – Revenue and Forecast to 2033 (US$ Billion)

11.5.1.2.1 Argentina: Hereditary Angioedema Treatment Market Breakdown, by Drug Class
11.5.1.2.2 Argentina: Hereditary Angioedema Treatment Market Breakdown, by Application
11.5.1.2.3 Argentina: Hereditary Angioedema Treatment Market Breakdown, by Route of Administration
11.5.1.2.4 Argentina: Hereditary Angioedema Treatment Market Breakdown, by Distribution Channel

11.5.1.3 Chile: Hereditary Angioedema Treatment Market – Revenue and Forecast to 2033 (US$ Billion)

11.5.1.3.1 Chile: Hereditary Angioedema Treatment Market Breakdown, by Drug Class
11.5.1.3.2 Chile: Hereditary Angioedema Treatment Market Breakdown, by Application
11.5.1.3.3 Chile: Hereditary Angioedema Treatment Market Breakdown, by Route of Administration
11.5.1.3.4 Chile: Hereditary Angioedema Treatment Market Breakdown, by Distribution Channel

11.5.1.4 Colombia: Hereditary Angioedema Treatment Market – Revenue and Forecast to 2033 (US$ Billion)

11.5.1.4.1 Colombia: Hereditary Angioedema Treatment Market Breakdown, by Drug Class
11.5.1.4.2 Colombia: Hereditary Angioedema Treatment Market Breakdown, by Application
11.5.1.4.3 Colombia: Hereditary Angioedema Treatment Market Breakdown, by Route of Administration
11.5.1.4.4 Colombia: Hereditary Angioedema Treatment Market Breakdown, by Distribution Channel

11.5.1.5 Peru : Hereditary Angioedema Treatment Market – Revenue and Forecast to 2033 (US$ Billion)

11.5.1.5.1 Peru : Hereditary Angioedema Treatment Market Breakdown, by Drug Class
11.5.1.5.2 Peru : Hereditary Angioedema Treatment Market Breakdown, by Application
11.5.1.5.3 Peru : Hereditary Angioedema Treatment Market Breakdown, by Route of Administration
11.5.1.5.4 Peru : Hereditary Angioedema Treatment Market Breakdown, by Distribution Channel

11.6 Middle East and Africa

11.6.1 Hereditary Angioedema Treatment Market Breakdown, by Key Country, 2026 and 2033 (%)
11.6.1.1 Hereditary Angioedema Treatment Market – Revenue and Forecast Analysis – by Country
11.6.1.1 Saudi Arabia: Hereditary Angioedema Treatment Market – Revenue and Forecast to 2033 (US$ Billion)

11.6.1.1.1 Saudi Arabia: Hereditary Angioedema Treatment Market Breakdown, by Drug Class
11.6.1.1.2 Saudi Arabia: Hereditary Angioedema Treatment Market Breakdown, by Application
11.6.1.1.3 Saudi Arabia: Hereditary Angioedema Treatment Market Breakdown, by Route of Administration
11.6.1.1.4 Saudi Arabia: Hereditary Angioedema Treatment Market Breakdown, by Distribution Channel

11.6.1.2 United Arab Emirates: Hereditary Angioedema Treatment Market – Revenue and Forecast to 2033 (US$ Billion)

11.6.1.2.1 United Arab Emirates: Hereditary Angioedema Treatment Market Breakdown, by Drug Class
11.6.1.2.2 United Arab Emirates: Hereditary Angioedema Treatment Market Breakdown, by Application
11.6.1.2.3 United Arab Emirates: Hereditary Angioedema Treatment Market Breakdown, by Route of Administration
11.6.1.2.4 United Arab Emirates: Hereditary Angioedema Treatment Market Breakdown, by Distribution Channel

11.6.1.3 Kuwait: Hereditary Angioedema Treatment Market – Revenue and Forecast to 2033 (US$ Billion)

11.6.1.3.1 Kuwait: Hereditary Angioedema Treatment Market Breakdown, by Drug Class
11.6.1.3.2 Kuwait: Hereditary Angioedema Treatment Market Breakdown, by Application
11.6.1.3.3 Kuwait: Hereditary Angioedema Treatment Market Breakdown, by Route of Administration
11.6.1.3.4 Kuwait: Hereditary Angioedema Treatment Market Breakdown, by Distribution Channel

11.6.1.4 Bahrain: Hereditary Angioedema Treatment Market – Revenue and Forecast to 2033 (US$ Billion)

11.6.1.4.1 Bahrain: Hereditary Angioedema Treatment Market Breakdown, by Drug Class
11.6.1.4.2 Bahrain: Hereditary Angioedema Treatment Market Breakdown, by Application
11.6.1.4.3 Bahrain: Hereditary Angioedema Treatment Market Breakdown, by Route of Administration
11.6.1.4.4 Bahrain: Hereditary Angioedema Treatment Market Breakdown, by Distribution Channel

11.6.1.5 Qatar: Hereditary Angioedema Treatment Market – Revenue and Forecast to 2033 (US$ Billion)

11.6.1.5.1 Qatar: Hereditary Angioedema Treatment Market Breakdown, by Drug Class
11.6.1.5.2 Qatar: Hereditary Angioedema Treatment Market Breakdown, by Application
11.6.1.5.3 Qatar: Hereditary Angioedema Treatment Market Breakdown, by Route of Administration
11.6.1.5.4 Qatar: Hereditary Angioedema Treatment Market Breakdown, by Distribution Channel

11.6.1.6 Oman: Hereditary Angioedema Treatment Market – Revenue and Forecast to 2033 (US$ Billion)

11.6.1.6.1 Oman: Hereditary Angioedema Treatment Market Breakdown, by Drug Class
11.6.1.6.2 Oman: Hereditary Angioedema Treatment Market Breakdown, by Application
11.6.1.6.3 Oman: Hereditary Angioedema Treatment Market Breakdown, by Route of Administration
11.6.1.6.4 Oman: Hereditary Angioedema Treatment Market Breakdown, by Distribution Channel

11.6.1.7 Turkiye: Hereditary Angioedema Treatment Market – Revenue and Forecast to 2033 (US$ Billion)

11.6.1.7.1 Turkiye: Hereditary Angioedema Treatment Market Breakdown, by Drug Class
11.6.1.7.2 Turkiye: Hereditary Angioedema Treatment Market Breakdown, by Application
11.6.1.7.3 Turkiye: Hereditary Angioedema Treatment Market Breakdown, by Route of Administration
11.6.1.7.4 Turkiye: Hereditary Angioedema Treatment Market Breakdown, by Distribution Channel

11.6.1.8 South Africa: Hereditary Angioedema Treatment Market – Revenue and Forecast to 2033 (US$ Billion)

11.6.1.8.1 South Africa: Hereditary Angioedema Treatment Market Breakdown, by Drug Class
11.6.1.8.2 South Africa: Hereditary Angioedema Treatment Market Breakdown, by Application
11.6.1.8.3 South Africa: Hereditary Angioedema Treatment Market Breakdown, by Route of Administration
11.6.1.8.4 South Africa: Hereditary Angioedema Treatment Market Breakdown, by Distribution Channel

11.6.1.9 Egypt: Hereditary Angioedema Treatment Market – Revenue and Forecast to 2033 (US$ Billion)

11.6.1.9.1 Egypt: Hereditary Angioedema Treatment Market Breakdown, by Drug Class
11.6.1.9.2 Egypt: Hereditary Angioedema Treatment Market Breakdown, by Application
11.6.1.9.3 Egypt: Hereditary Angioedema Treatment Market Breakdown, by Route of Administration
11.6.1.9.4 Egypt: Hereditary Angioedema Treatment Market Breakdown, by Distribution Channel

11.6.1.10 Nigeria: Hereditary Angioedema Treatment Market – Revenue and Forecast to 2033 (US$ Billion)

11.6.1.10.1 Nigeria: Hereditary Angioedema Treatment Market Breakdown, by Drug Class
11.6.1.10.2 Nigeria: Hereditary Angioedema Treatment Market Breakdown, by Application
11.6.1.10.3 Nigeria: Hereditary Angioedema Treatment Market Breakdown, by Route of Administration
11.6.1.10.4 Nigeria: Hereditary Angioedema Treatment Market Breakdown, by Distribution Channel

11.6.1.11 Algeria: Hereditary Angioedema Treatment Market – Revenue and Forecast to 2033 (US$ Billion)

11.6.1.11.1 Algeria: Hereditary Angioedema Treatment Market Breakdown, by Drug Class
11.6.1.11.2 Algeria: Hereditary Angioedema Treatment Market Breakdown, by Application
11.6.1.11.3 Algeria: Hereditary Angioedema Treatment Market Breakdown, by Route of Administration
11.6.1.11.4 Algeria: Hereditary Angioedema Treatment Market Breakdown, by Distribution Channel

12. Competitive Landscape

12.1 Heat Map Analysis

12.2 Company Positioning and Concentration

13. Industry Landscape

13.1 Overview

13.2 Market Initiative

13.3 Partnerships and Collaborations

13.4 Other Developments

14. Company Profiles

14.1 Takeda Pharmaceutical Company Limited

14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments

14.2 CSL Behring

14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments

14.3 Pharming Group N.V.

14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments

14.4 BioCryst Pharmaceuticals Inc.

14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments

14.5 Ionis Pharmaceuticals Inc.

14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments

14.6 KalVista Pharmaceuticals

14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments

14.7 Intellia Therapeutics

14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments

14.8 Adverum Biotechnologies

14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments

14.9 Cycle Pharmaceuticals

14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments

14.10 Astria Therapeutics

14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Products and Services
14.10.4 Financial Overview
14.10.5 SWOT Analysis
14.10.6 Key Developments

15. Appendix

15.1 About Business Market Insights

15.2 List of Abbreviations

Access the Full H Market Report

Get segment-level forecasts, regional estimates, competitive benchmarking, company profiles and downloadable Excel datasets.

Download Sample Request Customization